Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation
Clinical trial NCT04679012 · RECRUITING
Trial details
- NCT number
- NCT04679012
- Sponsor
- Weill Medical College of Cornell University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-24
- Primary completion
- 2026-09-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.